Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nimish Shah

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Annals of Hematology|February 28, 2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trialJames Russell, Angela Collins, Alexis Fowler, et al.
Journal of Thoracic Disease|July 10, 2019
Domiciliary use of transcutaneous electrical stimulation for patients with obstructive sleep apnoea: a conceptual framework for the TESLA home programmeBaiting He, Miral Al-Sherif, Miriam Nido, et al.
BJU International|June 10, 2021
New recommendations to reduce unnecessary blood tests after robot-assisted radical prostatectomyArjun Nathan, Nancy Hanna, Amir Rashid, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
British Journal of Haematology|February 16, 2019
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysisToby A Eyre, Amy A Kirkwood, Sat Gohill, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Annals of Hematology|February 28, 2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trialJames Russell, Angela Collins, Alexis Fowler, et al.
Journal of Thoracic Disease|July 10, 2019
Domiciliary use of transcutaneous electrical stimulation for patients with obstructive sleep apnoea: a conceptual framework for the TESLA home programmeBaiting He, Miral Al-Sherif, Miriam Nido, et al.
BJU International|June 10, 2021
New recommendations to reduce unnecessary blood tests after robot-assisted radical prostatectomyArjun Nathan, Nancy Hanna, Amir Rashid, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
British Journal of Haematology|February 16, 2019
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysisToby A Eyre, Amy A Kirkwood, Sat Gohill, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pageof 8